Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech to Redeem Convertible Senior Notes

NEW YORK (GenomeWeb News) – Life Technologies said on Friday it intends to redeem all of the outstanding 1.5 percent convertible senior notes due 2024.

The company intends to redeem the all of the notes on Feb. 15, and said that as of Dec. 31, 2011, $450 million in aggregate principal amount of the notes were outstanding. The notes are convertible prior to Feb. 14, 5 p.m. EST at a rate of 19.603 shares of common stock for each $1,000 principal amount of the notes surrendered.

The notes surrendered for conversion will be settled in cash and stock according to the provisions of the indentures.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.